| Literature DB >> 34335029 |
Marina White1, Ute D Feucht2,3,4, Louise de Villiers du Toit5, Theresa Rossouw3,4,5, Kristin L Connor1.
Abstract
The Siyakhula study is an ongoing, observational cohort study in Pretoria, South Africa, that aims to understand how maternal HIV infection and perinatal environmental factors shape development and health in infants who are HIV-exposed (in utero and during breastfeeding) but remain uninfected themselves (HEU). The Siyakhula Collaborative Workshop, which took place at the Research Centre for Maternal, Fetal, Newborn & Child Health Care Strategies at Kalafong Hospital in Pretoria, South Africa on November 15-16, 2018, brought together a group of international health scientists, clinicians, and stakeholders, including women with lived experience, to build capacity for research and training on the impact of HIV infection on women's and infants' health across geographical and disciplinary boundaries. The workshop sought to summarise the state of knowledge on the effects of being HEU on infant development and health in the first two years of life, identify gaps in existing research on modifiable exposures that may be associated with poor infant development, and develop ideas for novel research and interventions to lessen or prevent adverse health outcomes in pregnant or breastfeeding people living with HIV. These proceedings summarise the pre-workshop consensus process that was used to identify priority areas to discuss during small-group breakout sessions, as well as the themes and key challenges that emerged from these discussions during the workshop.Entities:
Keywords: HIV; PMTCT; breastfeeding; growth; immune; neurodevelopment
Year: 2021 PMID: 34335029 PMCID: PMC8319554 DOI: 10.2147/JMDH.S317829
Source DB: PubMed Journal: J Multidiscip Healthc ISSN: 1178-2390
Pre-Workshop Survey (Round 1) Distributed to Participants via Email
| 1. |
| 2.What are |
| 3. What |
| 4. If you were to design an interdisciplinary research programme aimed at improving the health outcomes of mothers and/or infants affected by HIV, what |
| 5. What |
| ● Maternal mental health and well-being |
| ● Maternal physical health (eg HIV status, weight, other disorders/disease, medication use) |
| ● Home environment |
| ● Support from partner, family, and/or community |
| ● Maternal level of education attained |
| ● Maternal socio-economic characteristics |
| ● Food security and/or quality of food |
| ● Accessibility to antenatal care |
| ● Other [fillable] |
| 6. What |
| ● Maternal mental health and well-being |
| ● Maternal physical health (eg HIV status, weight, infection, other disorders/disease, medication use) |
| ● Home environment |
| ● Support from partner, family, and/or community |
| ● Maternal level of education attained |
| ● Maternal socio-economic characteristics |
| ● Food security and/or quality of food |
| ● Breastfeeding practices |
| ● Infant language development |
| ● Infant cognitive development |
| ● Infant motor development |
| ● Infant behavioural development |
| ● Infant growth |
| ● Infant susceptibility to infection and disease |
| ● Accessibility of postnatal care |
| ● Other [fillable] |
| 7. What |
Figure 1Timeline of pre-workshop and workshop activities.
Figure 2Final results to question 1 of the workshop surveys following two rounds (via email and in-person) of feedback from workshop participants. ART education, safety, and adherence, understanding health risks for infants who are HEU, and safe breastfeeding practices were identified as the top key areas that must be addressed when aiming to improve health and well-being of mothers and infants affected by HIV, and were chosen as guiding discussion topics for breakout groups.
Figure 3Final results to questions 2–3, 5–6 of the workshop surveys following two rounds (via email and in-person) of feedback from workshop participants. Ideas generated in panels (A–D) supported and generated discussions throughout the breakout session and whole group discussions.
Guiding Questions Used by Moderators to Lead Small-Group Breakout Sessions
| 1. If we could do one thing related to ART safety and adherence, understanding the health risks for children who are HEU, or breastfeeding practices and food/nutrition security it would be … (why this one thing) |
| 2. What are the gaps in the present knowledge related to this one thing? |
| 3. What are the milestones along the way to completing this one thing? |
| 4. What are the stakes or consequences if this does not get done or if it does not go well? |
| 5. What is an example of success? |
| 1. What specific research questions are we looking to answer? |
| 2. How will the proposed research questions contribute to knowledge and understanding of the issue (the one thing)? |
| 3. What are our specific aims/objectives? |
| 4. What samples and/or data do we need to answer the research questions? |
| 5. What research design will be most effective in answering the research questions? |
| 6. What components would be most important to ensure the success of this research project in reaching its goals? |
Abbreviations: ART, antiretroviral therapy; HEU, HIV-exposed, uninfected.
Figure 4Final results to questions 4 (A) and 7 (B) of the workshop surveys following two rounds (via email and in-person) of feedback from workshop participants.
Figure 5Summary of perspectives shared by the women with lived experience at the workshop. Illustration of the barriers and opportunities to improve the health and well-being of women and children affected by HIV highlighted by the study participants in attendance throughout breakout group and whole-group discussions.
Research Questions Developed Through Small-Group Breakout Session Discussions That Aim to Address Key Concerns Highlighted as Guiding Themes
| 1. What are the drivers of non-adherence? Is it true non-adherence, or are they seeking health care elsewhere? |
| 2. What can we do to promote adherence? How can we increase disclosure of non-adherence? |
| 1. What components of the HEU phenotype are associated ART exposure (mom vs infant)? |
| 2. How does ongoing HIV viral replication alter the HEU phenotype? Will switching to new therapies effect the HEU phenotype? |
| 3. What is the weight of the various risk factors that are contributing? |
| 4. When do different types of neurodevelopmental dysfunctions emerge? |
| 1. Is there a difference in infant outcomes associated with mixed vs exclusive breastfeeding? |
| 2. Does food security impact BF practices? |
| 3. How does nutrition security affect BM composition and infant growth? |
| 4. How can we increase length of BF? What prevents mothers from meeting the guidelines? |
Abbreviations: ART, antiretroviral therapy; HEU, HIV-exposed, uninfected; BF, Breastfeeding; BM, Breastmilk.
Figure 6Summary of priority areas to address, and key challenges and opportunities identified through workshop discussions. To view the full infographic, visit: .